⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SILO News
Silo Pharma, Inc. Common Stock
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
globenewswire.com
SILO
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
globenewswire.com
SILO
Form 8-K
sec.gov
SILO
Form 8-K
sec.gov
SILO
Silo Pharma Announces Share Buyback Program
globenewswire.com
SILO
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
globenewswire.com
SILO
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
globenewswire.com
SILO
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
globenewswire.com
SILO
Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
globenewswire.com
SILO
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
globenewswire.com
SILO